Delivery Order SPE2DB22D1017-SPE2DB23FF9HF
Award Date 6/30/23
Potential Completion Date 7/3/23
Potential Value $775
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency awarded a $255,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561390734 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The prime contractor will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill requirements under the agency's logistics support program. No subcontractors or set aside designations were identified. The order was issued on June 30, 2023 with completion required by July 3, 2023.</p>
- The Defense Logistics Agency awarded a $13,464 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561904343 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a single day's supply of the specified pharmaceutical product to support DLA requirements. As the prime, Amerisourcebergen will fulfill the delivery itself without the involvement of major subcontractors. The contract...
- The Defense Logistics Agency awarded a $2,142 delivery order to Amerisourcebergen Drug Corporation for 4562291441 KONVOMEP 2-84 MG/ML ORAL SUSP 90ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide pharmaceutical products to DLA locations in Conshohocken, Pennsylvania from September 25-26, 2023. Amerisourcebergen will deliver the requested medication from its corporate headquarters and distribution facility without involvement of...
- The Defense Logistics Agency awarded a $3,519 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562058533 KONVOMEP 2-84 MG/ML ORAL SUSP 90ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 6-7, 2023. No major subcontractors or set aside designations were identified. This order is likely associated with DLA's medical supply program and will deliver pharmaceutical products to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,071 to Amerisourcebergen Drug Corporation for 4561534406 KONVOMEP 2-84 MG/ML ORAL SUSP 90ML. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. Performance is required between July 18-19, 2023. No set-aside designation or subcontractors were identified. As the DLA...
- The Defense Logistics Agency awarded a $376,790 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562020462 KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 1, 2023 in support of DLA programs. No major subcontractors or set aside designations were identified. DLA manages the global supply chain for the Department of Defense, ensuring troops have the medical supplies...
- The Defense Logistics Agency awarded a $510,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561376501 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The prime contractor will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by June 30, 2023. No additional details were provided regarding the original solicitation, any associated contracts or vehicles, subcontractors, or high-level DLA programs. The...
- Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp on October 17, 2023. The $714 firm fixed price order is for 4562520540 KONVOMEP 2-84 MG/ML ORAL SUSP 300ML to be delivered to a location in Conshohocken, Pennsylvania by October 18, 2023. No set-aside designation was applied to this procurement. Performance will be by corporate parent Amerisourcebergen Corporation, which does business as Amerisourcebergen. The Defense...
- The Defense Logistics Agency awarded a $1,071 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561490941 KONVOMEP 2-84 MG/ML ORAL SUSP 90ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 13, 2023 through July 14, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports military readiness by procuring, managing and distributing...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $9,816 to Amerisourcebergen Drug Corporation for 4561411218 KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 5-6, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by procuring nearly $20 billion worth...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FF9HFDelivery Order
The Defense Logistics Agency awarded a $775 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561390807 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility in support of the Defense Logistics Agency's medical supply chain programs. No major subcontractors or set aside designations were indicated. The delivery order has a period of performance from June 30, 2023 through July 3, 2023 to supply this medication to DLA customers.
Generated 12/22/23, 7:33 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $775 | 6/30/23 |